Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price target of $41.00. The company’s shares closed last ...
focusing on stocks such as Viridian Therapeutics, Ascendis Pharma, and Spyre Therapeutics. According to TipRanks, Thompson CFA has an average return of -1.2% and a 39.13% success rate on ...
FIRE IN AN EXPLOSION AT A WESTERN PENNSYLVANIA CHEMICAL PLANT. THIS IS IN SAGER TOWN BOROUGH IN CRAWFORD COUNTY, LESS THAN TWO HOURS NORTH OF PITTSBURGH. THANKS FOR JOINING US TONIGHT. I’M ...
After hours: February 7 at 5:43:24 PM EST ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Dyne Therapeutics Inc.-5.60% $1.56B ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback